The Trump administration plans to end a subsidy program that helped keep premiums low for Medicare drug plans, a move that could leave many seniors facing higher rates for their prescription coverage next year, Anna Wilde Mathews reported on July 28 for The Wall Street Journal. “The move will eliminate a program that is giving insurance companies an estimated $3.6 billion in subsidies this year to blunt increases in premiums for the Medicare prescription plans, known as Part D,” Wilde Mathews wrote. “The agency said the national base beneficiary premium for Medicare Part D will be $41.33 next year,” Ananthan reported. CMS announced it will release the 2027 MA and Part D landscape in mid-to-late September. Leading Medicare Part D insurers include UnitedHealth Group, Humana, and Aetna, a CVS Health company.